ACM
DGX icon

Americafirst Capital Management’s Quest Diagnostics DGX Stock Holding History

Americafirst Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-21,556
Closed -$1.66M – 213
2015
Q1 		$1.66M Buy
+21,556
New +$1.54M 0.82% 41

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Americafirst Capital Management's DGX Position: Q2 2015 in Review

Americafirst Capital Management sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 21,556 shares — an estimated $1.66M sold.

Americafirst Capital Management first reported a position in DGX in Q1 2015 and held it in 1 quarter. The position peaked at $1.66M in Q1 2015. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • Americafirst Capital Management reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
  • Americafirst Capital Management sold 21,556 Quest Diagnostics shares in Q2 2015, an estimated $1.66M.
  • Americafirst Capital Management first reported a position in Quest Diagnostics in Q1 2015 and held it in 1 quarter.
  • Americafirst Capital Management's Quest Diagnostics position peaked at $1.66M in Q1 2015.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Americafirst Capital Management's 13F filing for Q2 2015, filed 27 Jul 2015.